Facts About the UK
£56bn - Pharmaceuticals, medical biotechnology and medical technology sectors together comprise around 4,500 firms, employing 183,000 staff, with an R&D spend of nearly £5billion and an annual turnover of over £56 billion.
28% - of the life science workforce comes from companies supplying services and products to the industry such as clinical trial management, assay development, regulatory advice for a turnover of £17bn.
20 – The 20 top global pharmaceutical companies have sites in the UK representing 80% of the total sector employment.
20% - The UK has the largest biopharmaceutical pipeline in the EU, with 20% of biopharmaceuticals in development originating in the UK.
1000 - With more than 1000 medical biotechnology companies and over 3200 medical technology companies, the UK has one of the largest Life Sciences sectors in Europe.
3,200 - NIHR Clinical Research Networks supported the practical delivery of 1477 new clinical studies in 201-14 through the recruitment of over 600,000 patients.
* Information obtained from UK Trade & Investment
Click here to view companies within Cambridge.
Key strengths and opportunities of Cambridge
Multinational Pharma and Med Tech
• Cluster of potential academic, clinical and R&D partners
• Science Park, autonomous accommodation
• Highly networked innovation eco-system
Life Science Service Sector (Clinical)
• Proximity to development stage and large company customer base
• Access to clinical research KOLs in Academia and NHS
• Ex-Pharma talent pool
Development stage primary life science companies
• Cluster of potential academic, clinical and R&D partners
• Experienced commercial R&D talent pool
• Start-up and grown-on space potential
Life Science Service Sector (Technical)
• Proximity to customer R&D locations
• Entrepreneurial eco-system for early stage and high growth technical companies
• Start-up and grow-on space potential For more information on Life Sciences in London, please contact aline@onenucleus.com
